Defining Global Benchmarks in Bariatric Surgery Defining Global Benchmarks in Bariatric Surgery
A new study identifies benchmarks to define optimal surgical outcomes for the two most commonly performed bariatric procedures.Annals of Surgery
ConclusionThe MHI reflects severity of comorbidity, enabling objective assessment of a bariatric patient ’s metabolic health state, regardless day of sampling and surgery type. Next to weight-focused outcome measures like %TWL, the MHI can serve as outcome measure for metabolic health.
Nature Reviews Endocrinology, Published online: 14 November 2019; doi:10.1038/s41574-019-0292-5Bariatric surgery results in sustained weight loss and improvement in many obesity-related comorbidities. However, the effects of bariatric surgery on long-term mental health are less clear. A recent longitudinal cohort study shows that patients undergoing bariatric surgery seek mental health services at higher rates after surgery than before surgery and identifies specific risk factors for increased psychiatric service use.
AbstractIntroductionSleeve gastrectomy (SG) has overtaken Roux-En-Y gastric bypass (RYGB) as the most common bariatric procedure worldwide. However, there is little long-term data comparing the two procedures.ObjectivesWe perform a systematic review and meta-analysis comparing 5-year outcomes of randomised controlled trials (RCTs) comparing RYGB and SG.MethodsMedline, Embase, The Cochrane Library, and NHS Evidence were searched for English language RCTs comparing RYGB with SG and assessed weight loss and/or comorbidity resolution at 5 years.ResultsFive studies were included in the final analysis. Meta-analysis demonstrates...
Obesity is an independent risk factor for renal functional decline in people with chronic kidney disease and is highly prevalent amongst people with the leading cause of chronic kidney disease, diabetic kidney disease . Intentional weight loss strategies hold promise as a means of arresting progressive renal functional decline in diabetic kidney disease . Optimisation of renal outcomes after metabolic surgery centres on blood pressure and glycaemic control as well as addressing proteinuria.
SADIS was introduced in 2007 by S ánchez-Pernaute and is accepted as a modification of the widely accepted biliopancreatic diversion with duodeno switch (BPDDS). This paper from Enochs P, et al.1 represents an important addition to the body of growing literature regarding SADI-S and clinical outcomes. The comparison between SADI-S and established bariatric procedures is still limited and no papers either prospective or retrospective have examined weight loss, diabetes mellitus and nutritional status outcomes between SADI-S, RYGB and Sleeve Gastrectomy.
ConclusionObesity is closely associated with primary infertility and PCOD. Menstrual abnormalities associated with PCOD significantly improve after bariatric surgery with significant improvement in fertility along with maternal outcomes.
ConclusionThe results suggest that POPs may have an influence on the hypothalamic-pituitary-thyroid (HPT) and the hypothalamic-pituitary-gonadal (HPG) axes after bariatric surgery. Because of small sample sizes and discrepancy in the sampling time points pre- and postoperatively, the observed hormonal impacts of POPs must be interpreted as associative and not causative. Further studies are needed to confirm the findings.
New study suggests that a'threshold'of weight loss must be reached after bariatric surgery to see a reduced risk of obesity-related cancer. Another indicates risk may be reduced by around 20%.Medscape Medical News